Amedisys Inc (AMED)
95.42
-0.07
(-0.07%)
USD |
NASDAQ |
Nov 04, 16:00
95.37
-0.05
(-0.05%)
After-Hours: 20:00
Amedisys Revenue (Quarterly): 591.19M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 591.19M |
| March 31, 2024 | 571.41M |
| December 31, 2023 | 570.79M |
| September 30, 2023 | 556.24M |
| June 30, 2023 | 552.97M |
| March 31, 2023 | 556.39M |
| December 31, 2022 | 562.06M |
| September 30, 2022 | 557.99M |
| June 30, 2022 | 557.89M |
| March 31, 2022 | 545.26M |
| December 31, 2021 | 559.32M |
| September 30, 2021 | 553.48M |
| June 30, 2021 | 564.17M |
| March 31, 2021 | 537.14M |
| December 31, 2020 | 550.70M |
| September 30, 2020 | 544.07M |
| June 30, 2020 | 485.06M |
| March 31, 2020 | 491.68M |
| December 31, 2019 | 500.68M |
| September 30, 2019 | 494.63M |
| June 30, 2019 | 492.98M |
| March 31, 2019 | 467.34M |
| December 31, 2018 | 434.38M |
| September 30, 2018 | 417.34M |
| June 30, 2018 | 411.60M |
| Date | Value |
|---|---|
| March 31, 2018 | 399.26M |
| December 31, 2017 | 397.96M |
| September 30, 2017 | 373.70M |
| June 30, 2017 | 374.95M |
| March 31, 2017 | 364.66M |
| December 31, 2016 | 348.10M |
| September 30, 2016 | 361.60M |
| June 30, 2016 | 360.75M |
| March 31, 2016 | 348.82M |
| December 31, 2015 | 338.37M |
| September 30, 2015 | 326.45M |
| June 30, 2015 | 314.15M |
| March 31, 2015 | 301.57M |
| December 31, 2014 | 300.53M |
| September 30, 2014 | 300.28M |
| June 30, 2014 | 305.01M |
| March 31, 2014 | 298.74M |
| December 31, 2013 | 303.50M |
| September 30, 2013 | 301.28M |
| June 30, 2013 | 315.96M |
| March 31, 2013 | 328.60M |
| December 31, 2012 | 350.16M |
| September 30, 2012 | 364.34M |
| June 30, 2012 | 363.07M |
| March 31, 2012 | 370.83M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
485.06M
Minimum
Jun 2020
591.19M
Maximum
Jun 2024
547.82M
Average
556.24M
Median
Sep 2023
Revenue (Quarterly) Benchmarks
| Chemed Corp | 606.18M |
| Addus HomeCare Corp | 286.92M |
| Regional Health Properties Inc | 4.325M |
| OptimizeRx Corp | 18.81M |
| Option Care Health Inc | 1.279B |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 32.30M |
| Total Expenses (Quarterly) | 527.07M |
| EPS Diluted (Quarterly) | 0.98 |
| Enterprise Value | 3.417B |
| Gross Profit Margin (Quarterly) | 44.70% |
| Profit Margin (Quarterly) | 5.46% |
| Earnings Yield | 2.93% |
| Operating Earnings Yield | 6.67% |
| Normalized Earnings Yield | 4.051 |